Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Clinical trial NCT06947980 · RECRUITING

Trial details

NCT number: NCT06947980
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2025-06-19
Primary completion: 2026-07-18
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.